Alemtuzumab

FDA Drug Profile

Alemtuzumab is listed in the FDA National Drug Code directory with 4 NDC codes. Available dosage form: solution.

Drug details

Generic Name
Alemtuzumab
Sponsor
Boehringer Ingelheim Pharma GmbH And Co. KG
NDC Codes
4
Dosage Forms
SOLUTION
Active Ingredients
ALEMTUZUMAB

Indications and Usage

1 INDICATIONS AND USAGE CAMPATH is indicated as a single agent for the treatment of B-cell chronic lymphocytic leukemia (B-CLL). CAMPATH is a CD52-directed cytolytic antibody indicated as a single agent for the treatment of B-cell chronic lymphocytic leukemia (B-CLL). ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.